Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

308-nm excimer laser therapy helps regrow hair in alopecia areata.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Cyclosporine A can help some people with severe alopecia areata regrow hair.

Systemic corticosteroids don't prevent severe alopecia areata from spreading or relapsing.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

The steroid solution can regrow hair but often causes skin issues and doesn't work long-term.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Personality traits and anxiety affect hair loss patients' quality of life.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Quercetin effectively treated and prevented hair loss in mice.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Low vitamin D can worsen pediatric alopecia areata.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

The combined therapy was effective and safe for children with severe alopecia areata.

Lupus can look like hair loss from alopecia areata but needs different treatment.